Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 4NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 50Myelodysplastic Syndromes 40Leukemia, Myeloid, Acute 34Leukemia, Myelomonocytic, Chronic 33Leukemia 31Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Myeloproliferative Disorders 18Congenital Abnormalities 17Leukemia, Lymphocytic, Chronic, B-Cell 16Anemia, Refractory 15Blast Crisis 14Anemia 14Myelodysplastic-Myeloproliferative Diseases 10Lymphoma, Non-Hodgkin 10Leukemia, Myeloid, Chronic-Phase 10Leukemia, Myeloid, Accelerated Phase 9Leukemia, Megakaryoblastic, Acute 9Leukemia, Erythroblastic, Acute 9Neoplasms 8Lymphoma, Follicular 8Lymphoma 8Leukemia, Myelomonocytic, Acute 8Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 8Leukemia, Monocytic, Acute 8Anemia, Aplastic 8Lymphoma, Large B-Cell, Diffuse 7Hodgkin Disease 7Thrombocytopenia 6Multiple Myeloma 6Lymphoma, Mantle-Cell 6

Interventions

Stem Cell Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Severe Combined Immunodeficiency × Classical hematology × Clear all
NCT00000603 2016-04-14

Cord Blood Stem Cell Transplantation Study (COBLT)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 2 Completed
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Aplastic, Fanconi Anemia, Hematologic Diseases, Leukemia, Myelodysplastic Syndromes, Neoplasms, Severe Combined Immunodeficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡